# The Serum Sclerostin Levels in Cholesteatoma Patients

> **NCT03954288** · — · UNKNOWN · sponsor: **Abant Izzet Baysal University** · enrollment: 75 (estimated)

## Conditions studied

- Otitis Media Chronic
- Cholesteatoma

## Interventions

- **DIAGNOSTIC_TEST:** serum for sclerostin ELISA test

## Key facts

- **NCT ID:** NCT03954288
- **Lead sponsor:** Abant Izzet Baysal University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-29
- **Primary completion:** 2020-02-15
- **Final completion:** 2020-03-15
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2019-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03954288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03954288, "The Serum Sclerostin Levels in Cholesteatoma Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03954288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*